1. Bristol-Myers Squibb to Acquire IFM Therapeutics to Strengthen Oncology Pipeline Focus on Innate Immunity. https://news.bms.com/press-release/partnering-news/bristol-myers-squibb-acquire-ifm-therapeutics-strengthen-oncology-pipe.
2. IFM Therapeutics website. www.ifmthera.com/.
3. CSL Behring to Acquire Biotech Company Calimmune and its Proprietary Stem Cell Gene Therapy Platform. www.prnewswire.com/news-releases/csl-behring-to-acquire-biotech-company-calimmune-and-its-proprietary-stem-cell-gene-therapy-platform-300510086.html.
4. Calimmune. www.calimmune.com/.
5. CSL Behring. www.cslbehring.com/products.